| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8783153 | Medicina Reproductiva y Embriología Clínica | 2017 | 7 Pages |
Abstract
In patients with a normal response prognosis, controlled ovarian stimulation with corifollitropin alpha, shows no statistically significant differences with conventional treatment, and represents a comfortable alternative for the patient, since it improves adherence to treatment in those with established normal response prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
José MarÃa Rubio, Isauro Rogelio Monfort, Irene Juárez, Roser Taroncher, Susana MartÃnez, Vicente Montañana, Antonio Pellicer,